The department was founded in 1983 initiated by Prof. Wang Jingbo、Xi Ning & Wu Dake with high reputations in China, which started to treat patients on May, 1987, with the guidance of Prof. He Yirong. With the help of famous oncologists Yu Zihao, Yin weibo & Xu guozheng from the Chinese Academy of Medical Sciences Cancer Institute & Hospital, the primary expert team led by Prof. Lang Jinyi has been composed with the mission of cancer diagnosis and treatnemt in 1990. In 2003, the Dept. was nominated as Class A key medical center of Sichuan Province, which is the only one in the field of tumor radiotherapy in Sichuan, up to now. In 2013, Prof. Lang served as the chairman of Chinese Society for Radiation Oncology（CSTRO）. In 2014, it was built as a national key clinical Department of Oncology.
Since its inception, the department has maintained its position as a provincial leader in providing expert, compassionate, prompt cancer care, high quality teaching and research. Treating more than 5,000 patients a year, the department is one of the largest in China.
Prof. Lang Jinyi serves as the Chairman and academic leader, and Prof. Li Tao, Wang Weidong, Wang Pei and Zhang shichuan are the deputy directors of the Department.
Figure1 Centre organized architecture diagram
2.Equipments and facilities
This department is equipped with world-class advanced hardware and software for radiotherapy system, which can meet different needs for patients with various social and economical backgrounds, providing the sate-of-art treatment for patients.
Fihure2 List oftreatment facilities
Professor Lang Jinyi, entitled with “the national middle-aged expert with outstanding contributions”, “Ministry of Health Oncology academic and technological leaders (first batch)”, “provincial academic and technological leaders “and “the State Council allowance medical experts”, “health consultation center experts”, “Sichuan outstanding scientific and technological workers”.
Figure3.The core team composition
The department has made remarkable achievements in the cultivation of high talent experts, there are currently four returned Ph.Ds., 14 doctoral and postdoctoral, 33 employees has a Ｍaster degree, more than 15 employee were sent to abroad in recent years for further study more than six months. 2 professors have been titled provincial government academic and technological leaders (Second class professor), two government allowances of experts of the State Council, two provincial outstanding contribution experts, two provincial health department academic leaders, one provincial health department candidates for a scholarship.
4. Clinical Priorities and advantages
The department is divided into three sub-disciplines, including the division of head and neck which treats patients with nasopharyngeal, oropharyngeal cancer, hypopharyngeal cancer, nasal cancer, oral cancer, laryngeal cancer, etc; the division of chest for patients with lung, esophagus and chest wall, mediastinal tumors, etc; The division of pelvic and abdominal for patients with colorectal cancer, stomach cancer, breast cancer, prostate cancer, cervical cancer. After the implementation of specialist groups, for different tumor types, the establishment of a comprehensive and detailed diagnosis and treatment of individual processes and radiation norms, improve the professionalism and effectiveness of diagnosis and treatment, and promote various specialist clinical platforms for carrying out the clinical trials. Currently, more than 10 clinical trials are undergoing in the center.
4.2.Multidisciplinary treatment (MDT)
On the basis of the implementation of specialist grouped by disease, the center actively participate in and promote the building of tumor multimodality therapy Cooperative Group, whose purpose is to improve and follow different cancer diagnostic and treatment practices, based on multi-disciplinary learning system, consultation system, discussion system and resource sharing system, to carry out clinical and basic cancer research, provide individualized treatment for each patient to ensure efficacy. Currently, nasopharyngeal cancer, lung cancer, esophageal cancer, breast cancer, gynecological cancer and other MDT have been running.
The center pays special attention to the construction of the Centre radiotherapy technology priorities in recent years, under the precise medical guidance, to further regulate the principles of cancer treatment, with the leading of professor Lang Jinyi, adaptive radiotherapy（ART）for nasopharyngeal carcinoma and squamous cell carcinoma of head and neck, SBRT treatment for lung cancer and liver cancer, IMRT compensated 3D-brachytherapy for cervical cancer etc, the treatment outcomes have reached or exceeded the international advanced level.
5.Training and scientific research
In the past five years, the department has published nearly 200 papers, including more than 50 Science cited index listed journals, more than 10 outstanding papers. An annual contribution of about 5-10 abstracts at the ASTRO annual meetings as a Poster, and 1-2 oral presentation yearly. More than 50 scientific projects supported by various foundations are undergoing, including National Natural Science Foundation of China, Ministry of Science and major projects, major research and development programs, as well as provincial projects. More than 30 patents, nearly 20 scientific awards were achieved in the past five years.
The department was named as the national radiotherapy specialist training base from 2013 to now. As associate editor of the first China radiotherapy specialist training textbook, we joined the national specialist training team. From 2016, it developed into a comprehensive cancer center affiliated to University of Electronic Science and Technology of China（UESTC）, which builds a complete training system from undergraduate student to doctoral candidates, also including the clinical oncology professional training of undergraduate, Ｍasters and doctoral students from Guangxi Medical University, Southwest Medical University, North Sichuan Medical College and Chengdu Medical College.
With the coming of new era of Internet, life genomics and big data, the department will uphold the "patient-centered" as basic principles, to develop precise diagnosis and treatment technology, aim to allow each patient to get the best effect, lowest cost "customized " treatment, make our endeavor to turn the department into a leading domestic and international first-class radiotherapy center!